Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exact Imaging has commercialized the ExactVu micro-ultrasound system—the world’s first 29 MHz micro-ultrasound platform. It provides real-time, high-resolution imaging for targeted and systematic prostate biopsies. The device offers a 300% improvement in resolution over conventional ultrasound and enables visualization comparable to MRI. The system has received regulatory approvals including FDA 510(k) clearance (US), CE Mark (EU), and Health Canada license[1][4][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exact Imaging.